Drug intelligence / Profile preview

VARA

Development stage
Preclinical
Lead developer
Virginia Tech
Modality
Small Molecules
Administration
Oral
01

Overview

VARA is an experimental combination of vitamin A metabolites consisting of retinyl palmitate (a storage form of vitamin A) and all-trans-retinoic acid (tRA). In the studied formulation, it is prepared as a mixture where tRA represents 10% of the retinol equivalent provided by retinyl palmitate (specifically 11.2 mg/kg retinyl palmitate mixed with 0.6 mg/kg tRA). Developed for research purposes, particularly in the context of systemic lupus erythematosus (SLE), VARA is used to investigate the complex and sometimes paradoxical effects of vitamin A on autoimmune pathogenesis. While retinoids like tRA are known to have anti-inflammatory properties and can ameliorate lupus nephritis, research indicates that the VARA combination may exacerbate neuroinflammation and neurodegeneration in lupus-prone MRL/lpr mice, leading to increased brain weight, astrogliosis, and immune complex deposition in the central nervous system.

Other names
retinyl palmitate + all-trans-retinoic acidVitamin A + Retinoic Acidretinol + tRA mixture
02

Targets

RARA (Retinoic acid receptor alpha)RARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)

Beyond the preview

Go deeper on VARA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VARA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call